Chicago’s license for pharmaceutical sales representatives is now part of U.S. Senate legislation and a state bill in New Jersey as lawmakers look for new ways to battle the opioid crisis.
Cardiologists are scrambling to explain why the negative results of a big and important new clinical trial of a lucrative, frequently performed procedure should not change the way they treat patients.